Financial Ratios Cipla Limited

Stocks

CIPLA

INE059A01026

Pharmaceuticals

Market Closed - NSE India S.E. 07:05:08 2026-09-01 EDT			5-day change	1st Jan Change
1,423.00 ^INR	+0.98%		-1.04%	-5.84%

08-25	Cipla's Pithampur, India Unit Gets 7 Observations From US FDA	MT
08-13	Cipla Announces Appointment of Runa Akhtar to Marketing Head, Cipla Urology	CI

100d96fefff8d5c5c1a19fe9df7.GrB50VGOjrK2EgRftdEfrm0vrRLbIMRREEQTwI2xsA4.VuNUtGf4v_j1IG0MjPxGyzJl_HuuWIx8Yid0q-GG-lxP0wHgNNjpgeV0dw

Published financial data: CIPLA LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	216B	225B	254B	271B	277B
Other Revenues, Total	845M	861M	901M	1.22B	1.16B
Total Revenues	217B	226B	255B	273B	278B
Cost of Goods Sold, Total	86.9B	84.55B	90.44B	91.75B	98.1B
Gross Profit	130B	141B	165B	181B	180B
Selling General & Admin Expenses, Total	46.67B	50.15B	54.9B	61.07B	67.75B
Depreciation & Amortization - (IS)	9.9B	10.19B	9.42B	9.99B	10.84B
Other Operating Expenses	37.98B	40.62B	47.12B	48.58B	53.18B
Other Operating Expenses, Total	94.55B	101B	111B	120B	132B
Operating Income	35.63B	40.08B	53.49B	61.29B	48.41B
Interest Expense, Total	-1.05B	-1.08B	-711M	-440M	-482M
Interest And Investment Income	796M	1.62B	2.2B	2.64B	2.07B
Net Interest Expenses	-252M	547M	1.48B	2.2B	1.59B
Income (Loss) On Equity Invest.	-128M	-26M	-15.9M	-218M	-80.5M
Currency Exchange Gains (Loss)	216M	651M	1.01B	-91.3M	525M
Other Non Operating Income (Expenses)	621M	765M	3.04B	2.83B	1.99B
EBT, Excl. Unusual Items	36.08B	42.01B	59.01B	66.01B	52.43B
Impairment of Goodwill	-	-1.82B	-	-	-
Gain (Loss) On Sale Of Investments	772M	1.48B	692M	1.74B	3.03B
Gain (Loss) On Sale Of Assets	86.8M	15.8M	44.2M	-50.6M	318M
Asset Writedown	-619M	-1.53B	-1.09B	-1.08B	-1.27B
Insurance Settlements	275M	199M	298M	154M	53.8M
Legal Settlements	26.7M	-	-	1.21B	356M
Other Unusual Items	-1.82B	-	-1.95B	-	-2.76B
EBT, Incl. Unusual Items	34.8B	40.36B	57B	67.99B	52.16B
Income Tax Expense	9.34B	12.03B	15.47B	15.3B	13.54B
Earnings From Continuing Operations	25.47B	28.33B	41.54B	52.69B	38.62B
Net Income to Company	25.47B	28.33B	41.54B	52.69B	38.62B
Minority Interest	-299M	-310M	-322M	33.2M	175M
Net Income - (IS)	25.17B	28.02B	41.22B	52.73B	38.79B
Net Income to Common Incl Extra Items	25.17B	28.02B	41.22B	52.73B	38.79B
Net Income to Common Excl. Extra Items	25.17B	28.02B	41.22B	52.73B	38.79B
Per Share Items
Net EPS - Basic	31.2	34.72	51.05	65.29	48.03
Basic EPS - Continuing Operations	31.2	34.72	51.05	65.29	48.03
Basic Weighted Average Shares Outstanding	807M	807M	807M	808M	808M
Net EPS - Diluted	31.17	34.69	51.01	65.24	48
Diluted EPS - Continuing Operations	31.17	34.69	51.01	65.24	48
Diluted Weighted Average Shares Outstanding	807M	808M	808M	808M	808M
Normalized Basic EPS	27.59	32.16	45.29	51.13	40.78
Normalized Diluted EPS	27.56	32.13	45.25	51.09	40.76
Dividend Per Share	5	8.5	13	13	13
Payout Ratio	16.03	14.4	16.65	19.91	33.32
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	44.39B	49.19B	61.91B	70.22B	58.03B
EBITA	38.35B	42.95B	55.72B	63.84B	51.5B
EBIT	35.63B	40.08B	53.49B	61.29B	48.41B
EBITDAR	45.17B	50.06B	62.83B	71.34B	59.32B
Total Revenues (As Reported)	220B	232B	265B	284B	290B
Effective Tax Rate - (Ratio)	26.83	29.81	27.13	22.5	25.96
Total Current Taxes	11.37B	12.65B	16.97B	17.08B	14.41B
Total Deferred Taxes	-2.03B	-619M	-1.5B	-1.79B	-871M
Normalized Net Income	22.25B	25.95B	36.56B	41.29B	32.94B
Interest on Long-Term Debt	183M	193M	211M	230M	283M
Non-Cash Pension Expense	500K	-9.5M	-800K	63.3M	2.74B
Supplemental Operating Expense Items
Advertising Expense	10.59B	10.98B	10.87B	11.62B	12.79B
Selling and Marketing Expenses	10.59B	10.98B	10.87B	11.62B	12.79B
Research And Development Expense From Footnotes	2.66B	3.86B	15.23B	14.85B	19.22B
Net Rental Expense, Total	782M	869M	926M	1.12B	1.29B
Imputed Operating Lease Interest Expense	426M	804M	773M	788M	947M
Imputed Operating Lease Depreciation	356M	64.53M	153M	330M	345M
Maintenance & Repair Expenses, Total	1.95B	2.03B	2.24B	2.46B	2.61B
Stock-Based Comp., SG&A Exp. (Total)	241M	390M	462M	473M	590M
Total Stock-Based Compensation	241M	390M	462M	473M	590M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	6.78B	6.28B	6.4B	5.89B	10.18B
Short Term Investments	17.59B	27.34B	23.49B	27.35B	13.3B
Trading Asset Securities, Total	21.95B	30.9B	48.07B	72.93B	76.79B
Total Cash And Short Term Investments	46.32B	64.52B	77.96B	106B	100B
Accounts Receivable, Total	34.24B	40.57B	47.71B	55.06B	56.2B
Other Receivables	1.68B	2.45B	3.9B	3.11B	3.64B
Notes Receivable	35.7M	75.9M	2.4M	156M	231M
Total Receivables	35.96B	43.09B	51.61B	58.33B	60.07B
Inventory	53.5B	51.56B	52.38B	56.42B	65.97B
Prepaid Expenses	1.11B	1.13B	1.33B	1.53B	1.8B
Other Current Assets, Total	10.39B	7.75B	11.14B	10.43B	13.35B
Total Current Assets	147B	168B	194B	233B	241B
Gross Property Plant And Equipment	98.06B	103B	109B	121B	138B
Accumulated Depreciation	-41.98B	-45.97B	-48.79B	-54.75B	-61.8B
Net Property Plant And Equipment	56.09B	57.4B	60.47B	65.86B	76.26B
Long-term Investments	6.79B	5.74B	10.53B	8.11B	16.21B
Goodwill	31.38B	29.84B	31.12B	32.7B	37.54B
Other Intangibles, Total	17.03B	15.3B	16.01B	17.16B	30.96B
Loans Receivable Long-Term	400K	-	170M	326M	27.6M
Deferred Tax Assets Long-Term	4.49B	4.57B	5.88B	6.45B	9.01B
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	7.96B	13.74B	8.59B	10.37B	13.47B
Total Assets	271B	295B	327B	374B	425B
Liabilities
Accounts Payable, Total	25.08B	24.57B	24.74B	28.37B	32.3B
Accrued Expenses, Total	6.96B	6.67B	8.92B	8.92B	9.63B
Short-term Borrowings	3.93B	1.88B	2.48B	814M	1.4B
Current Portion of Long-Term Debt	146M	3.32B	-	-	-
Current Portion of Leases	734M	739M	870M	1.06B	913M
Current Income Taxes Payable	206M	166M	220M	768M	54.5M
Unearned Revenue Current, Total	199M	466M	268M	390M	530M
Other Current Liabilities	11.88B	13.28B	14.96B	14.51B	25.31B
Total Current Liabilities	49.13B	51.1B	52.46B	54.84B	70.14B
Long-Term Debt	4.16B	-	-	120M	1.17B
Long-Term Leases	1.58B	2.09B	2.25B	2.4B	2.64B
Unearned Revenue Non Current	515M	521M	619M	568M	490M
Pension & Other Post Retirement Benefits	1B	1.02B	1.29B	1.49B	1.58B
Deferred Tax Liability Non Current	2.44B	1.63B	1.85B	535M	1.53B
Other Non Current Liabilities	1B	1.14B	678M	1.02B	2.2B
Total Liabilities	59.84B	57.5B	59.15B	60.98B	79.76B
Common Stock, Total	1.61B	1.61B	1.61B	1.62B	1.62B
Additional Paid In Capital	16.32B	16.53B	16.73B	16.93B	17.07B
Retained Earnings	188B	212B	246B	288B	314B
Comprehensive Income and Other	2.35B	3.92B	2.88B	5.5B	12.02B
Total Common Equity	208B	234B	267B	312B	344B
Minority Interest	2.76B	3.06B	959M	958M	883M
Total Equity	211B	237B	268B	313B	345B
Total Liabilities And Equity	271B	295B	327B	374B	425B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	807M	807M	807M	808M	808M
ECS Total Common Shares Outstanding	807M	807M	807M	808M	808M
Book Value / Share	258.32	290.01	330.78	386.24	426.25
Tangible Book Value	160B	189B	220B	262B	276B
Tangible Book Value Per Share	198.32	234.08	272.41	324.5	341.45
Total Debt	10.56B	8.03B	5.6B	4.39B	6.14B
Net Debt	-35.76B	-56.49B	-72.36B	-102B	-94.14B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-63.8M	56.9M	1.04B	358M	359M
Debt Equivalent Oper. Leases	6.25B	6.95B	7.41B	8.95B	10.34B
Minority Interest, Total (Incl. Fin. Div)	2.76B	3.06B	959M	958M	883M
Equity Method Investments, Total	458M	909M	1.3B	1.4B	1.12B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	18.55B	16.85B	16.83B	17.29B	19.17B
Inventories - Work In Process, Total	8.52B	8.64B	8.16B	8.53B	9.48B
Inventories - Finished Goods, Total	25.6B	26.44B	26.29B	29.23B	35.72B
Inventories - Others	832M	1.08B	1.1B	1.37B	1.6B
Land - (BS)	832M	897M	817M	874M	890M
Buildings, Total	28.63B	28.7B	28.05B	28.81B	32.92B
Machinery, Total	60.79B	62.08B	66.09B	72.93B	83.86B
Full Time Employees	25.93K	32.32K	27.76K	30.31K	31.37K
Accumulated Allowance for Doubtful Accounts (Supple)	1.81B	1.25B	1.39B	1.01B	1.06B

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	25.17B	28.02B	41.22B	52.73B	38.79B
Depreciation & Amortization - CF	6.84B	7.05B	7.04B	7.29B	7.63B
Amortization of Goodwill and Intangible Assets - (CF)	2.73B	2.87B	2.23B	2.55B	3.09B
Depreciation & Amortization, Total	9.56B	9.92B	9.26B	9.84B	10.72B
Amortization of Deferred Charges, Total - (CF)	340M	274M	152M	118M	113M
(Gain) Loss From Sale Of Asset	-86.8M	-15.8M	-44.2M	50.6M	-318M
(Gain) Loss on Sale of Investments - (CF)	-792M	-1.69B	-2.91B	-4.09B	-4.31B
Asset Writedown & Restructuring Costs	619M	1.53B	1.09B	1.12B	1.27B
Provision for Credit Losses	-	-	-	-	-
Stock-Based Compensation (CF)	241M	390M	462M	473M	590M
Provision and Write-off of Bad Debts	-408M	-367M	235M	89.3M	83.6M
Other Operating Activities, Total	393M	-88.9M	-66.3M	-3.62B	-5.3B
Change In Accounts Receivable	814M	-6.52B	-9.07B	-8.02B	4.65B
Change In Inventories	-6.21B	1.11B	-619M	-3.23B	-6.42B
Change In Accounts Payable	3.62B	-182M	1.63B	4.59B	2.53B
Change in Other Net Operating Assets	-	-	-	-	-3.01B
Cash from Operations	33.26B	32.38B	41.34B	50.05B	39.4B
Capital Expenditure	-5.44B	-8.41B	-10.98B	-11.62B	-15.99B
Sale of Property, Plant, and Equipment	314M	296M	342M	248M	497M
Cash Acquisitions	-	-	-3.01B	-2.05B	-1.11B
Divestitures	-	-	1.2B	-	-
Sale (Purchase) of Intangible assets	-1.53B	-3.24B	-2.51B	-3.77B	-14.36B
Investment in Marketable and Equity Securities, Total	-12.64B	-13.76B	-17.38B	-22.3B	5.4B
Other Investing Activities, Total	584M	1.22B	2.46B	2.59B	2.3B
Cash from Investing	-18.72B	-23.89B	-29.88B	-36.91B	-23.26B
Short Term Debt Issued, Total	350M	-	-	-	946M
Long-Term Debt Issued, Total	-	-	-	120M	932M
Total Debt Issued	350M	-	-	120M	1.88B
Short Term Debt Repaid, Total	-	-3.08B	-3B	-980M	-
Long-Term Debt Repaid, Total	-11.33B	-1.78B	-770M	-802M	-1.08B
Total Debt Repaid	-11.33B	-4.86B	-3.77B	-1.78B	-1.08B
Issuance of Common Stock	700K	700K	400K	500K	400K
Common Dividends Paid	-4.03B	-4.04B	-6.86B	-10.5B	-12.92B
Common & Preferred Stock Dividends Paid	-4.03B	-4.04B	-6.86B	-10.5B	-12.92B
Special Dividend Paid	-	-	-	-	-
Other Financing Activities, Total	-982M	-693M	-1.37B	-767M	-212M
Cash from Financing	-16B	-9.58B	-12B	-12.93B	-12.34B
Foreign Exchange Rate Adjustments	134M	124M	55.6M	92.6M	925M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-1.32B	-968M	-490M	303M	4.73B
Supplemental Items
Cash Interest Paid	757M	650M	648M	364M	370M
Cash Income Tax Paid (Refund)	11.4B	13.02B	15.97B	16.68B	15.86B
Levered Free Cash Flow	23.09B	19.63B	26.86B	26.67B	11.4B
Unlevered Free Cash Flow	23.75B	20.3B	27.3B	26.94B	11.7B
Change In Net Working Capital	1.69B	3.69B	2.52B	6.4B	-372M
Net Debt Issued / Repaid	-10.98B	-4.86B	-3.77B	-1.66B	800M

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	8.52	8.86	10.75	10.93	7.58
Return on Total Capital	10.41	10.73	12.89	12.97	9.05
Return On Equity %	12.83	12.64	16.45	18.14	11.74
Return on Common Equity	12.85	12.66	16.45	18.21	11.82
Margin Analysis
Gross Profit Margin %	59.97	62.52	64.58	66.35	64.75
SG&A Margin	21.5	22.23	21.5	22.4	24.35
EBITDA Margin %	20.45	21.8	24.24	25.75	20.85
EBITA Margin %	17.67	19.04	21.82	23.41	18.51
EBIT Margin %	16.41	17.77	20.95	22.48	17.4
Income From Continuing Operations Margin %	11.73	12.56	16.27	19.32	13.88
Net Income Margin %	11.59	12.42	16.14	19.34	13.94
Net Avail. For Common Margin %	11.59	12.42	16.14	19.34	13.94
Normalized Net Income Margin	10.25	11.5	14.32	15.14	11.84
Levered Free Cash Flow Margin	10.64	8.7	10.52	9.78	4.1
Unlevered Free Cash Flow Margin	10.94	9	10.69	9.88	4.2
Asset Turnover
Asset Turnover	0.83	0.8	0.82	0.78	0.7
Fixed Assets Turnover	3.86	3.98	4.33	4.32	3.92
Receivables Turnover (Average Receivables)	6.29	6.01	5.77	5.28	4.98
Inventory Turnover (Average Inventory)	1.73	1.61	1.74	1.69	1.6
Short Term Liquidity
Current Ratio	3	3.29	3.71	4.25	3.44
Quick Ratio	1.67	2.1	2.47	3	2.28
Operating Cash Flow to Current Liabilities	0.68	0.63	0.79	0.91	0.56
Days Sales Outstanding (Average Receivables)	57.98	60.75	63.48	69.09	73.27
Days Outstanding Inventory (Average Inventory)	210.41	226.78	210.33	216.41	227.68
Average Days Payable Outstanding	89.09	109.68	100.44	101.19	102.86
Cash Conversion Cycle (Average Days)	179.3	177.85	173.37	184.31	198.09
Long Term Solvency
Total Debt/Equity	5	3.39	2.09	1.4	1.78
Total Debt / Total Capital	4.76	3.28	2.05	1.38	1.75
LT Debt/Equity	2.72	0.88	0.84	0.81	1.11
Long-Term Debt / Total Capital	2.59	0.85	0.82	0.8	1.09
Total Liabilities / Total Assets	22.08	19.51	18.08	16.31	18.77
EBIT / Interest Expense	33.98	37.26	75.21	139.23	100.37
EBITDA / Interest Expense	43.1	46.49	88.23	161.58	122.61
(EBITDA - Capex) / Interest Expense	37.91	38.67	72.79	135.18	89.44
Total Debt / EBITDA	0.23	0.16	0.09	0.06	0.1
Net Debt / EBITDA	-0.79	-1.13	-1.15	-1.43	-1.59
Total Debt / (EBITDA - Capex)	0.27	0.19	0.11	0.07	0.14
Net Debt / (EBITDA - Capex)	-0.9	-1.36	-1.4	-1.71	-2.18
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.53	3.92	13.2	6.78	2.06
Gross Profit, 1 Yr. Growth %	12.08	8.35	16.94	9.7	-0.41
EBITDA, 1 Yr. Growth %	7.64	10.81	25.85	13.43	-17.36
EBITA, 1 Yr. Growth %	8.81	11.98	29.75	14.57	-19.33
EBIT, 1 Yr. Growth %	9.64	12.49	33.48	14.57	-21.02
Earnings From Cont. Operations, 1 Yr. Growth %	6.62	11.24	46.62	26.85	-26.71
Net Income, 1 Yr. Growth %	4.65	11.33	47.1	27.93	-26.43
Normalized Net Income, 1 Yr. Growth %	9.64	16.61	40.89	12.94	-20.22
Diluted EPS Before Extra, 1 Yr. Growth %	4.63	11.29	47.05	27.9	-26.43
Accounts Receivable, 1 Yr. Growth %	-0.62	18.47	17.59	15.42	2.06
Inventory, 1 Yr. Growth %	14.59	-3.62	1.58	7.72	16.92
Net Property, Plant and Equip., 1 Yr. Growth %	-0.71	2.34	5.35	8.92	15.79
Total Assets, 1 Yr. Growth %	7.75	8.72	11.05	14.27	13.66
Tangible Book Value, 1 Yr. Growth %	18.6	18.08	16.41	19.16	5.24
Common Equity, 1 Yr. Growth %	13.72	12.31	14.09	16.8	10.38
Cash From Operations, 1 Yr. Growth %	-11.43	-2.65	27.68	21.07	-21.28
Capital Expenditures, 1 Yr. Growth %	-13.59	54.48	30.66	5.82	37.62
Levered Free Cash Flow, 1 Yr. Growth %	-7.8	-21.6	102.53	-0.71	-57.25
Unlevered Free Cash Flow, 1 Yr. Growth %	-8.67	-20.99	97.09	-1.32	-56.57
Dividend Per Share, 1 Yr. Growth %	0	70	52.94	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.73	8.62	8.46	9.94	4.39
Gross Profit, 2 Yr. CAGR %	9.12	10.2	12.56	13.26	4.52
EBITDA, 2 Yr. CAGR %	20.08	9.21	18.09	19.48	-3.18
EBITA, 2 Yr. CAGR %	25.36	10.38	20.53	21.92	-3.86
EBIT, 2 Yr. CAGR %	29.64	11.06	22.54	23.67	-4.87
Earnings From Cont. Operations, 2 Yr. CAGR %	30.32	8.91	27.71	36.38	-3.58
Net Income, 2 Yr. CAGR %	27.57	7.94	27.97	37.18	-2.98
Normalized Net Income, 2 Yr. CAGR %	29.7	13.07	28.18	26.15	-5.08
Diluted EPS Before Extra, 2 Yr. CAGR %	27.55	7.91	27.93	37.14	-3
Accounts Receivable, 2 Yr. CAGR %	-6.19	8.51	18.03	16.5	8.54
Inventory, 2 Yr. CAGR %	10.55	5.09	-1.06	4.6	12.22
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.57	0.8	3.83	7.12	12.3
Total Assets, 2 Yr. CAGR %	7.02	8.23	9.87	12.65	13.97
Tangible Book Value, 2 Yr. CAGR %	21	18.34	17.24	17.77	11.99
Common Equity, 2 Yr. CAGR %	14.99	13.02	13.2	15.44	13.55
Cash From Operations, 2 Yr. CAGR %	4.11	-7.15	11.49	24.33	-2.37
Capital Expenditures, 2 Yr. CAGR %	-2.53	15.54	42.07	17.59	20.68
Levered Free Cash Flow, 2 Yr. CAGR %	10.8	-11.47	3.57	41.8	-34.85
Unlevered Free Cash Flow, 2 Yr. CAGR %	8.98	-11.64	3.08	39.46	-34.53
Dividend Per Share, 2 Yr. CAGR %	29.1	30.38	61.25	23.67	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.97	9.72	10.13	7.9	7.25
Gross Profit, 3 Yr. CAGR %	7.79	8.86	12.4	11.6	8.51
EBITDA, 3 Yr. CAGR %	12.74	16.9	14.5	16.52	5.66
EBITA, 3 Yr. CAGR %	16.43	20.73	16.49	18.51	6.24
EBIT, 3 Yr. CAGR %	20.4	23.65	18.08	19.82	6.5
Earnings From Cont. Operations, 3 Yr. CAGR %	19.5	23.62	20.26	27.43	10.88
Net Income, 3 Yr. CAGR %	18.1	21.91	19.67	27.96	11.45
Normalized Net Income, 3 Yr. CAGR %	19.24	25.18	21.67	22.88	8.28
Diluted EPS Before Extra, 3 Yr. CAGR %	18.09	21.88	19.64	27.92	11.43
Accounts Receivable, 3 Yr. CAGR %	-6.21	1.4	11.46	17.15	11.48
Inventory, 3 Yr. CAGR %	10.51	5.61	3.91	1.79	8.56
Net Property, Plant and Equip., 3 Yr. CAGR %	0.61	0.39	2.3	5.5	9.93
Total Assets, 3 Yr. CAGR %	4.19	7.58	9.16	11.32	12.99
Tangible Book Value, 3 Yr. CAGR %	16.06	20.02	17.69	17.88	13.44
Common Equity, 3 Yr. CAGR %	11.56	14.09	13.37	14.39	13.73
Cash From Operations, 3 Yr. CAGR %	25.29	1.81	3.25	14.59	6.76
Capital Expenditures, 3 Yr. CAGR %	14.75	13.64	20.37	28.78	23.92
Levered Free Cash Flow, 3 Yr. CAGR %	47.38	1.43	2.35	2.12	-4.92
Unlevered Free Cash Flow, 3 Yr. CAGR %	42.33	0.51	1.64	1.59	-5.47
Dividend Per Share, 3 Yr. CAGR %	18.56	41.5	37.51	37.51	15.21
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	8.66	8.35	9.36	9.81	7.79
Gross Profit, 5 Yr. CAGR %	7.39	8.02	9.67	10.6	9.18
EBITDA, 5 Yr. CAGR %	12.06	11.9	14.85	17.93	7.07
EBITA, 5 Yr. CAGR %	14.21	14.36	18.05	21.2	7.88
EBIT, 5 Yr. CAGR %	16.34	16.21	21.25	23.66	8.3
Earnings From Cont. Operations, 5 Yr. CAGR %	19.72	14.87	22.72	28.58	10.09
Net Income, 5 Yr. CAGR %	20.12	14.71	21.96	27.8	10.04
Normalized Net Income, 5 Yr. CAGR %	19.56	16.57	22.74	25.57	10.17
Diluted EPS Before Extra, 5 Yr. CAGR %	20.05	14.67	21.93	27.77	10.01
Accounts Receivable, 5 Yr. CAGR %	5.97	5.51	2.82	7.19	10.28
Inventory, 5 Yr. CAGR %	8.95	4.98	5.73	5.21	7.16
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.43	-0.31	1.89	3.03	6.19
Total Assets, 5 Yr. CAGR %	5.2	5.21	6.43	9.58	11.06
Tangible Book Value, 5 Yr. CAGR %	17.65	15.67	16.53	19.12	15.38
Common Equity, 5 Yr. CAGR %	10.69	10.47	12.21	14.63	13.44
Cash From Operations, 5 Yr. CAGR %	6.91	17.22	19.57	10.28	0.97
Capital Expenditures, 5 Yr. CAGR %	-13.69	3.56	24.99	15.2	20.49
Levered Free Cash Flow, 5 Yr. CAGR %	20.98	41.42	30.07	7.23	-14.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.15	37.35	27.08	6.15	-14.76
Dividend Per Share, 5 Yr. CAGR %	20.11	23.16	34.08	34.08	21.06